Scientists identify potential contributor to hyper immune responses in patients with severe COVID-19

February 23, 2021

Researchers have pinpointed a helper T cell population in the lungs of patients with severe COVID-19 that may be central to the development of hyperinflammation, lung injury, and subsequent acute respiratory distress syndrome (ARDS) during disease. Their data support the ongoing investigation of anti-cytokine therapies that target this cell subset, called tissue-resident memory-like Th17 cells (Trm17). To date, the bulk of research on immune responses to COVID-19 has mainly focused on T cells in the blood, while the role of tissue-specific immune cells in the inflamed lung has remained unclear. Accumulating evidence suggests that one of the causes of ARDS and, ultimately, death in COVID-19 patients is a hyperactive immune system, fueling exploration into drugs to block molecules that contribute to hyperactivation. Now, using a combination of single-cell RNA sequencing, cell surface protein sequencing, and T cell analyses, Yu Zhao and colleagues identified a helper T cell subset in the lungs of patients with severe COVID-19 that express high levels of GM-CSF and IL-17A, molecules both implicated in heightened immune activation and inflammation. The researchers collected samples from blood and lung fluid of patients with severe COVID-19 and patients with bacterial pneumonia. CD4+ cells and, in particular, Trm17 cells were more clonally expanded in the lungs of the virally infected group. Levels of GM-CSF and IL-17A in the lungs positively correlated with disease severity in COVID-19 patients. As well, the researchers found Trm17 cells could potentially interact with other cells associated with COVID-19 severity and lung damage, such as lung macrophages and CD8+ killer T cells. Based on their results, the authors postulate that Trm17 cells may become activated as part of a cytokine storm, during which they start producing inflammatory molecules like GM-CSF. In future work, Zhao et al. hope to validate their findings in a larger patient cohort.

American Association for the Advancement of Science

Related Immune Responses Articles from Brightsurf:

Dissecting the immune characteristics of severe COVID-19 responses
A team of immunology experts from research organisations in Belgium and the UK have come together to apply their pioneering research methods to put individuals' COVID-19 response under the microscope.

Uracil switch in SARS-CoV-2 genome alters innate immune responses
Our bodies could be inducing mutations in the COVID-19 virus that activate immune cells to increase the production of pro-inflammatory molecules.

The making of memory B cells and long-term immune responses
Researchers at Osaka University in Japan have identified two factors necessary for the production of memory B cells, the cells of the immune system that allow fast responses to re-infection.

Identification of a viral factor that impairs immune responses in COVID-19 patients
A research team at The Institute of Medical Science, The University of Tokyo (IMSUT) aimed to characterize the viral factor(s) determining immune activation upon SARS-CoV-2 infection and found that ORF3b, a gene encoded by SARS-CoV-2, is a potent IFN antagonist.

Children with COVID-19 show different immune responses, but better outcomes than adults
A comparison of children and adults hospitalized with COVID-19 reveals pediatric patients, who had better outcomes and shorter hospital stays, displayed altered immune responses and more limited production of antibodies against infection.

Modeling future COVID-19 cases under a variety of immune responses, and with or without vaccines
Researchers who adapted standard epidemiological models to explore how the COVID-19 pandemic trajectory might unfold in the next five years report diverse scenarios ranging from recurring severe epidemics to elimination.

Allergic immune responses help fight bacterial infections
Researchers from CeMM, MedUni Vienna and Stanford University, have found that a module of the immune system, best known for causing allergic reactions, plays a key role in acquiring host defense against infections triggered by the bacterium Staphylococcus aureus.

Delayed immune responses may drive COVID-19 mortality rates among men and the elderly
COVID-19 (SARS-CoV-2) infections tend to be more severe among older adults and males, yet the mechanisms underlying increased mortality in these two demographics are unknown.

Detailed study of immune responses in COVID-19 patients reveals distinct 'immunotypes'
Expanding on observations made in smaller patient cohorts, researchers studying immune responses of 125 hospitalized COVID-19 patients identified distinct immune profiles -- ''Immunotypes'' -- and showed how these signatures correlated with disease severity.

Penn researchers find three distinct immune responses for sicker COVID-19 patients
Researchers from the Penn Institute of Immunology discovered three distinct immune responses to the SARS-CoV2 infection that could help predict the trajectory of disease in severe COVID-19 patients and may ultimately inform how to best treat them.

Read More: Immune Responses News and Immune Responses Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to